BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23599180)

  • 21. NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.
    Li X; Guan B; Maghami S; Bieberich CJ
    Mol Cell Biol; 2006 Apr; 26(8):3008-17. PubMed ID: 16581776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase casein kinase 2 holoenzyme produced ectopically in human cells can be exported to the external side of the cellular membrane.
    Rodríguez F; Allende CC; Allende JE
    Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4718-23. PubMed ID: 15774585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of a novel testis-specific gene CKT2, which encodes a substrate for protein kinase CK2.
    Bai X; Silvius D; Chan ED; Escalier D; Xu SX
    Nucleic Acids Res; 2009 May; 37(8):2699-711. PubMed ID: 19273531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The activity of CK2 in the extracts of COS-7 cells transfected with wild type and mutant subunits of protein kinase CK2.
    Korn I; Jacob G; Allende CC; Allende JE
    Mol Cell Biochem; 2001 Nov; 227(1-2):37-44. PubMed ID: 11827173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BID, an interaction partner of protein kinase CK2alpha.
    Olsen BB; Petersen J; Issinger OG
    Biol Chem; 2006 Apr; 387(4):441-9. PubMed ID: 16606343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yeast elf1 factor is phosphorylated and interacts with protein kinase CK2.
    Kubinski K; Zielinski R; Hellman U; Mazur E; Szyszka R
    J Biochem Mol Biol; 2006 May; 39(3):311-8. PubMed ID: 16756761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene targeting of CK2 catalytic subunits.
    Seldin DC; Lou DY; Toselli P; Landesman-Bollag E; Dominguez I
    Mol Cell Biochem; 2008 Sep; 316(1-2):141-7. PubMed ID: 18594950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KIF5C: a new binding partner for protein kinase CK2 with a preference for the CK2alpha' subunit.
    Schäfer B; Götz C; Dudek J; Hessenauer A; Matti U; Montenarh M
    Cell Mol Life Sci; 2009 Jan; 66(2):339-49. PubMed ID: 19011756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predominance of CK2α over CK2α' in the mammalian brain.
    Ceglia I; Flajolet M; Rebholz H
    Mol Cell Biochem; 2011 Oct; 356(1-2):169-75. PubMed ID: 21761202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development.
    Lou DY; Dominguez I; Toselli P; Landesman-Bollag E; O'Brien C; Seldin DC
    Mol Cell Biol; 2008 Jan; 28(1):131-9. PubMed ID: 17954558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1.
    Gibson SA; Yang W; Yan Z; Qin H; Benveniste EN
    J Immunol; 2018 Jul; 201(2):383-392. PubMed ID: 29891553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of the individual subunits of protein kinase CK2 and of hPrp3p to the splicing process.
    Dörr J; Kartarius S; Götz C; Montenarh M
    Mol Cell Biochem; 2008 Sep; 316(1-2):187-93. PubMed ID: 18553058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activity.
    Llorens F; Roher N; Miró FA; Sarno S; Ruiz FX; Meggio F; Plana M; Pinna LA; Itarte E
    Biochem J; 2003 Nov; 375(Pt 3):623-31. PubMed ID: 12901717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protein kinase CK2(Andante) holoenzyme structure supports proposed models of autoregulation and trans-autophosphorylation.
    Schnitzler A; Olsen BB; Issinger OG; Niefind K
    J Mol Biol; 2014 May; 426(9):1871-82. PubMed ID: 24594356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: effect of the regulatory subunit.
    Baier A; Nazaruk J; Galicka A; Szyszka R
    Mol Cell Biochem; 2018 Jul; 444(1-2):35-42. PubMed ID: 29188536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells.
    Kreutzer JN; Ruzzene M; Guerra B
    BMC Cancer; 2010 Aug; 10():440. PubMed ID: 20718998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between CK2α and CK2β, the subunits of protein kinase CK2: thermodynamic contributions of key residues on the CK2α surface.
    Raaf J; Bischoff N; Klopffleisch K; Brunstein E; Olsen BB; Vilk G; Litchfield DW; Issinger OG; Niefind K
    Biochemistry; 2011 Feb; 50(4):512-22. PubMed ID: 21142136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of apoptosis repressor with caspase recruitment domain by protein kinase CK2 contributes to chemotherapy resistance by inhibiting doxorubicin induced apoptosis.
    Wang J; Feng C; He Y; Ding W; Sheng J; Arshad M; Zhang X; Li P
    Oncotarget; 2015 Sep; 6(29):27700-13. PubMed ID: 26172393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying interaction motifs in CK2beta--a ubiquitous kinase regulatory subunit.
    Bolanos-Garcia VM; Fernandez-Recio J; Allende JE; Blundell TL
    Trends Biochem Sci; 2006 Dec; 31(12):654-61. PubMed ID: 17084631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners.
    Litchfield DW; Bosc DG; Canton DA; Saulnier RB; Vilk G; Zhang C
    Mol Cell Biochem; 2001 Nov; 227(1-2):21-9. PubMed ID: 11827170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.